Skip to main navigation Skip to search Skip to main content

EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge

  • Christopher F. Bassil
  • , Kerry Dillon
  • , Gray R. Anderson
  • , Benjamin Mayro
  • , Kayleigh N. Askin
  • , Peter S. Winter
  • , Stefan Harry
  • , Samuel Gruber
  • , Tierney M. Hall
  • , Jacob P. Hoj
  • , Christian Cerda-Smith
  • , Haley M. Hutchinson
  • , Shane T. Killarney
  • , Ava Heffernan
  • , Caroline Teddy
  • , Katherine R. Singleton
  • , Li Qin
  • , Kévin Jubien-Girard
  • , Cécile Favreau
  • , Guillaume Robert
    • Barr Tivon, Ella Livnah, Nir London, Rachid Benhida, Patrick Auberger, Ann Marie Pendergast, Liron Bar-Peled, David M. Lonard, Anthony R. Martin, Alexandre Puissant, Kris C. Wood*
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Citation (Scopus)

Fingerprint

Dive into the research topics of 'EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology